Clinical Trial Update: Multiple Omics Sequencing Technologies in Predicting the Efficacy and Monitoring the Recurrence of Non-Small Cell Lung Cancer

View source ↗

Summary

This clinical trial is evaluating multiple omics sequencing technologies to predict treatment efficacy in non-small cell lung cancer and to monitor recurrence. …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences | Conditions: Non Small Cell Lung Cancer | Status: RECRUITING